view1-Page Ltd

1-Page Limited signs two major enterprises as clients


1-Page Limited (ASX:1PG) has signed two large enterprises to leverage its Sourcing Platform to find, attract and engage talented candidates.

These include a Fortune 50 telecommunications company with a market capitalisation of more than US$170 billion and a Fortune 100 technology company capitalised at more than US$130 billion.

This demonstrates both the demand for its platform as well as the company’s ability to scale its efforts to partner with the largest companies in the world to assist them in sourcing the best talent.

Signing the two large enterprises further strengthens 1-Pages’ offering in the technology industry as well as opening up another additional U.S. vertical within telecommunications.

Adding interest, the company now has on its active client roster two of the top 10 technology companies (Apple, HP, IBM, Microsoft, Amazon, Google, Cisco, Dell and Ingram Micro), which employ more than 1.4 million people.

The 1-Page Sourcing Platform leverages 1.15 billion professional profiles with enriched data from 70 different online sources.

The platform allows companies to source candidates from within their own employee’s networks, displaying a selection of the most connected and qualified candidates to the company’s workforce.

1-Page allows the hiring team to contact, attract, and engage the most valuable passive candidates at scale.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: 1-Page Ltd

Price: - -

Market: ASX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


ANGLE completes FDA submission for Parsortix system for metastatic breast cancer

ANGLE PLC's (LON:AGL, OTCQX:ANPCY) Andrew Newland talks to Proactive's Katie Pilbeam after announcing the completion of their submission to the FDA for its Parsortix PC1 liquid biopsy for use in women with metastatic breast cancer (MBC). Newland calls the announcement 'a massive day' after...

14 minutes ago

2 min read